EE200100041A - Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod - Google Patents

Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod

Info

Publication number
EE200100041A
EE200100041A EEP200100041A EEP200100041A EE200100041A EE 200100041 A EE200100041 A EE 200100041A EE P200100041 A EEP200100041 A EE P200100041A EE P200100041 A EEP200100041 A EE P200100041A EE 200100041 A EE200100041 A EE 200100041A
Authority
EE
Estonia
Prior art keywords
compound
preparation
coat
antifungic
inert core
Prior art date
Application number
EEP200100041A
Other languages
English (en)
Inventor
Picornell Darder Carlos
Original Assignee
Liconsa, Liberacion Controlada De Sustancias Activas, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200100041(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa, Liberacion Controlada De Sustancias Activas, S.A. filed Critical Liconsa, Liberacion Controlada De Sustancias Activas, S.A.
Publication of EE200100041A publication Critical patent/EE200100041A/et
Publication of EE04415B1 publication Critical patent/EE04415B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EEP200100041A 1998-07-21 1999-07-20 Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod EE04415B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (2)

Publication Number Publication Date
EE200100041A true EE200100041A (et) 2002-06-17
EE04415B1 EE04415B1 (et) 2005-02-15

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100041A EE04415B1 (et) 1998-07-21 1999-07-20 Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod

Country Status (30)

Country Link
US (1) US6737082B1 (et)
EP (1) EP1103252B1 (et)
JP (1) JP4190732B2 (et)
KR (1) KR100572135B1 (et)
AT (1) ATE234077T1 (et)
AU (1) AU750730B2 (et)
BG (1) BG65187B1 (et)
BR (1) BR9912300A (et)
CA (1) CA2337509C (et)
CZ (1) CZ291938B6 (et)
DE (1) DE69905905T2 (et)
DK (1) DK1103252T3 (et)
EE (1) EE04415B1 (et)
ES (2) ES2157731B1 (et)
HR (1) HRP20010128B1 (et)
HU (1) HU228895B1 (et)
IL (1) IL140910A (et)
ME (1) MEP26708A (et)
MX (1) MXPA01000681A (et)
NO (1) NO320054B1 (et)
NZ (1) NZ509886A (et)
PL (1) PL194740B1 (et)
PT (1) PT1103252E (et)
RS (1) RS50063B (et)
RU (1) RU2209628C2 (et)
SK (1) SK283279B6 (et)
TR (1) TR200100177T2 (et)
UA (1) UA64009C2 (et)
WO (1) WO2000004881A1 (et)
ZA (1) ZA200101293B (et)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1122456C (zh) * 1996-01-31 2003-10-01 南亚拉巴马医学科学基金会 含有天然的还原叶酸盐异构体的食品和维生素制品
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DZ3227A1 (fr) 1999-12-23 2001-07-05 Pfizer Prod Inc Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DK1438961T4 (da) * 2003-01-14 2014-11-17 Acino Pharma Ag Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
SI1438960T2 (sl) * 2003-01-14 2013-04-30 Cimex Pharma Ag Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljšano biorazpoložljivostjo
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
CN1822843B (zh) * 2003-07-17 2010-04-28 泰博特克药品有限公司 制备含有抗病毒药物颗粒的方法
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US8653083B2 (en) 2005-08-22 2014-02-18 The Johns Hopkins University Hedgehog pathway antagonists to treat disease
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
JP2013521249A (ja) * 2010-03-05 2013-06-10 ビーエーエスエフ ソシエタス・ヨーロピア 融解物で被覆された医薬形態
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
WO2016189481A1 (en) * 2015-05-25 2016-12-01 Sun Pharmaceutical Industries Limited Once daily oral pharmaceutical composition of isotretinoin
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
KR102419769B1 (ko) 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 약물 조성물
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
WO2019208801A1 (ja) * 2018-04-27 2019-10-31 凸版印刷株式会社 徐放性複合粒子、徐放性複合粒子の製造方法、乾燥粉体及び壁紙
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease
EP4452232A1 (en) * 2021-12-22 2024-10-30 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
TW349870B (en) * 1993-09-30 1999-01-11 Janssen Pharmaceutica Nv An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
DK0904060T3 (da) * 1996-05-20 2004-04-13 Janssen Pharmaceutica Nv Antifungale præparater med forbedret biotilgængelighed
ZA974428B (en) * 1996-05-24 1997-11-24 Schering Corp Antifungal composition with enhanced bioavailability.
NZ333514A (en) * 1996-06-28 2000-05-26 Schering Corp Oral pharmaceutical composition comprising a triazole antifungal compound
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
WO1998042318A1 (en) 1997-03-26 1998-10-01 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer

Also Published As

Publication number Publication date
ZA200101293B (en) 2001-08-21
HK1037531A1 (en) 2002-02-15
JP2002521323A (ja) 2002-07-16
NO20010289D0 (no) 2001-01-17
KR20010070990A (ko) 2001-07-28
PT1103252E (pt) 2003-07-31
KR100572135B1 (ko) 2006-04-19
YU3901A (sh) 2003-08-29
BR9912300A (pt) 2001-04-17
HU228895B1 (en) 2013-06-28
BG105282A (en) 2001-11-30
EE04415B1 (et) 2005-02-15
CZ2001175A3 (en) 2001-05-16
IL140910A0 (en) 2002-02-10
RU2209628C2 (ru) 2003-08-10
ES2194480T3 (es) 2003-11-16
BG65187B1 (bg) 2007-06-29
IL140910A (en) 2004-03-28
US6737082B1 (en) 2004-05-18
CA2337509A1 (en) 2000-02-03
CZ291938B6 (cs) 2003-06-18
SK862001A3 (en) 2001-08-06
DE69905905D1 (de) 2003-04-17
CA2337509C (en) 2005-12-27
NZ509886A (en) 2002-09-27
RS50063B (sr) 2009-01-22
ES2157731A1 (es) 2001-08-16
NO320054B1 (no) 2005-10-17
EP1103252B1 (en) 2003-03-12
AU750730B2 (en) 2002-07-25
HRP20010128B1 (en) 2003-12-31
WO2000004881A1 (es) 2000-02-03
ATE234077T1 (de) 2003-03-15
HRP20010128A2 (en) 2002-12-31
MEP26708A (en) 2010-06-10
TR200100177T2 (tr) 2001-07-23
HUP0103708A3 (en) 2002-07-29
ES2157731B1 (es) 2002-05-01
JP4190732B2 (ja) 2008-12-03
HUP0103708A2 (hu) 2002-02-28
PL194740B1 (pl) 2007-06-29
UA64009C2 (en) 2004-02-16
EP1103252A1 (en) 2001-05-30
PL345625A1 (en) 2002-01-02
NO20010289L (no) 2001-03-07
DK1103252T3 (da) 2003-07-14
MXPA01000681A (es) 2002-04-24
DE69905905T2 (de) 2004-03-04
SK283279B6 (sk) 2003-05-02
AU4782199A (en) 2000-02-14

Similar Documents

Publication Publication Date Title
EE04415B1 (et) Antimükootilist toimet omava ühendi farmatseutiline peroraalne preparaat ja selle valmistamismeetod
DE69431807D1 (de) Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung
CA2314078A1 (en) Coating of polymers
CA2322875A1 (en) A coated chewing gum, a method for preparation thereof and the use of one or more active substance(s) in solid form
BR9915087A (pt) Formulação farmacêutica oral revestida entérica, uso de uma qualidade de hidroxipropil celulose (hpc), processo para a munufatura de uma formulação farmacêutica oral revestida entérica, uso de uma formulação farmacêutica, e, método para o tratamento de doenças gastrointestinais em mamìferos, incluindo o homem
DK76892D0 (da) Genstand med friktionsnedsaettende overfladebelaegning samt fremgangsmaade til fremstilling af en saadan belagt genstand
AU2940200A (en) Hydrophilic member, method for preparation thereof, and coating agent and apparatus for preparation thereof
EP0351760A3 (en) Feed additive for ruminants
RU2001104894A (ru) Пероральная фармацевтическая композиция на основе соединения, имеющего антигрибковую активность, и способ ее получения
PT869774E (pt) Metodo para a producao de particulas de libertacao retardada
FI891163A0 (fi) Kontrollerat frigoerande farmaceutiskt preparat och foerfarande foer framstaellning av detta.
DK0868912T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater til coating af farmaceutiske eller agrokemiske applikationsformer
BRPI0407116A (pt) Partìcula revestida baseada em princìpio ativo, composição farmacêutica ou cosmética, e, método para produção de partìcula revestida com princìpio ativo
ATE97567T1 (de) Eine suspension hydratisierter spheroide einer hydrophilen lipidsubstanz enthaltendes waessriges kosmetisches bzw. dermopharmazeutisches mittel.
FR2816507B1 (fr) Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
EP0998944A3 (en) Enteric coated formulation of a benzimidazole derivative and method for preparation thereof
IE900391L (en) N-(3-pyridyl) guanidine derivative
AU5320998A (en) Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
IT9048080A0 (it) Nuovi penam-derivati e loro sali, procedimento per la loro produzione ed agente antibatterico che li contiene.
JPS55113592A (en) Method of manufacturing pressure-sensitive recording paper
JPS6426513A (en) Coating of solid drug
ITRM950421A0 (it) 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare, procedimento per la loro preaparazione e composizioni farmaceutiche che li contengono.
JPS60137017A (ja) レジスト塗布装置
ES8800838A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
YU31302A (sh) Flaster za produženo lečenje bubuljica i postupak dobijanja

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20140720